ResearchViews Home
Login
Registration
Home
Latest News
Latest Deals
Report Store
Contact Us
Sign up for our FREE Weekly
Women's Health
ResearchViews Update.
Please enter your email address below
*
:
Related Industries
Pharma
Cardiovascular
Central Nervous System
Dermatology
ENT Disorders
Gastroenterology
Genito Urinary System and Sex Hormones
Hematology Disorders
Hormonal Disorders
Immunology
Infectious Disease
Male Health
Metabolic Disorders
Mouth and Dental Disorders
Musculoskeletal
Oncology
Ophthalmology
Respiratory
Women's Health
Medical
Cardiovascular Devices
Dental Devices
Diabetes Care Devices
Diagnostic Imaging
Drug Delivery Devices
Endoscopy Devices
ENT Devices
Healthcare IT
Hospital Supplies
In Vitro Diagnostics
Nephrology and Urology Devices
Neurology Devices
Ophthalmic Devices
Orthopedic Devices
Patient Monitoring
Respiratory Devices
Surgical Equipment
Wound Care Management
"
"
Click Here
Free Research Papers
Latest Women's Health Reports
Latest Women's Health Deals
Pacgen Biopharmaceuticals Amends Licensing Agreement With Demegen For PAC-113
Published: Jan 30 2012
Repros Therapeutics Completes Private Placement Of Shares For $11.1 Million
Published: Jan 27 2012
Watson Pharmaceuticals Acquires Ascent Pharmahealth From Strides Arcolab And Dennis Bastas For $394 Million
Published: Jan 24 2012
Neurocrine Biosciences Completes Over-allotment Option Of Underwritten Public Offering For $88.5 Million
Published: Jan 18 2012
Synageva BioPharma Completes Public Offering Of Common Stock For $90 Million
Published: Jan 04 2012
Latest Women's Health News
Aeterna Zentaris Reports Updated Phase I Trial Results For AEZS-108 In Prostate Cancer At ASCO GCS Meeting
Date of story: Feb 03 2012
Keller Rohrback Announces Investigation Of Pfizer Regarding Lo/Ovral-28 And Norgestrel Birth Control Pill Recall
Date of story: Feb 03 2012
Dr. Reddy’s Reports Revenue Of $522m In Q3 Fiscal 2012
Date of story: Feb 03 2012
HRA Pharma Receives FDA Advisory Committee's Recommendation For Approval Of Ulipristal Acetate For Emergency Contraception
Date of story: Feb 02 2012
PregLem Announces Full Results Of PEARL I And II Studies Of Esmya Published In New England Journal Of Medicine
Date of story: Feb 02 2012
Latest Women's Health Reports
Women’s Health Therapeutics Market to 2017 - High Unmet Need will Drive Uptake of Novel Drugs Such as Prolia and Odanocantib in the Menopause and Osteoporosis Markets
By: GBI Research, Published: Dec-2011
Polycystic Ovarian Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2018
By: GlobalData, Published: Nov-2011
Premenstrual Syndrome - Pipeline Review, H2 2011
By: Global Markets Direct, Published: Nov-2011
Contraceptives Market to 2017 - Hormonal Contraceptives and Strong Pipeline to Drive the Growth in Future
By: GBI Research, Published: Oct-2011
Female Sexual Dysfunction - Pipeline Review, H2 2011
By: Global Markets Direct, Published: Oct-2011